SCHEMBL26468776

SCHEMBL26468776

CC1(C)c2ccccc2-c2ccc3c(c21)C(C)(C)c1cc(-c2ccc(-c4ccc5ccc6cccnc6c5n4)c4ccccc24)ccc1-3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.37
AVPR2 P30518 1/20 0.37
AVPR1A P37288 1/20 0.37
CCR1 P32246 4/20 0.36
CCR8 P51685 4/20 0.36
CCR5 P51681 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
LMNA P02545 2/20 0.36
GMNN O75496 1/20 0.36
TP53 P04637 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MMP2 P08253 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MMP9 P14780 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26469950 0.94 CCR1 (0.38) BACE1AVPR2AVPR1ACCR1CCR8
SCHEMBL26468803 0.92 CCR1 (0.36) BACE1AVPR2AVPR1ACCR1CCR8
SCHEMBL26468828 0.92 BACE1 (0.34) BACE1AVPR2AVPR1ACCR1CCR8
SCHEMBL26468596 0.92 BACE1 (0.36) BACE1AVPR2AVPR1ACCR1CCR8
SCHEMBL26468786 0.91 CCR1 (0.36) BACE1AVPR2AVPR1ACCR1CCR8
SCHEMBL26468834 0.89 CCR1 (0.34) BACE1AVPR2AVPR1ACCR1CCR8
SCHEMBL26468793 0.86 ALOX5 (0.36) BACE1AVPR2AVPR1ACCR1CCR8
SCHEMBL17522021 0.85 CCR1 (0.40) BACE1AVPR2AVPR1ACCR1CCR8
SCHEMBL26468813 0.84 CCR1 (0.33) BACE1AVPR2AVPR1ACCR1CCR8
SCHEMBL26468762 0.84 ALOX5 (0.35) BACE1AVPR2AVPR1ACCR1CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137213-A1 NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2023-05-04 US disclosed
US-20230137213-A1 NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137213-A1 NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME PPOX, PAH, CRY2 BACE1 260/4885AVPR2 3770/4885AVPR1A 3511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.